首页> Drugs> Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial.

Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial.

导出 OA

翻译打印收藏纠错

第一作者： Susan,Abushakra

第一单位： Alzheon, Inc, 111 Speen Street, Suite 306, Framingham, MA, 01701, USA. susan.abushakra@alzheon.com.

作者： Susan,Abushakra ^[1] ; Aidan,Power ^[2] ; David,Watson ^[3] ; Anton,Porsteinsson ^[4] ; Marwan,Sabbagh ^[5] ; Emer,MacSweeney ^[6] ; Sharon,Cohen ^[7] ; Mercè,Boada Rovira ^[8] ; P Murali,Doraiswamy ^[9] ; Earvin,Liang ^[2] ; Susan,Flint ^[2] ; J Patrick,Kesslak ^[2] ; Rosalind,McLaine ^[2] ; Adem,Albayrak ^[2] ; Jean,Schaefer ^[2] ; Jeremy,Yu ^[2] ; Luke,Tolar ^[2] ; Sam,Dickson ^[10] ; John A,Hey ^[2] ; Martin,Tolar ^[2]

作者单位： Alzheon, Inc, 111 Speen Street, Suite 306, Framingham, MA, 01701, USA. susan.abushakra@alzheon.com. ^[1] Alzheon, Inc, 111 Speen Street, Suite 306, Framingham, MA, 01701, USA. ^[2] Alzheimer's Research and Treatment Center, Wellington, FL, USA. ^[3] School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA. ^[4] Barrow Neurological Institute, Phoenix, AZ, USA. ^[5] ReCognition Health, London, UK. ^[6] Toronto Memory Program, Toronto, Canada. ^[7] International University of Catalunya, Barcelona, Spain. ^[8] Departments of Psychiatry and Medicine, Duke University School of Medicine, Durham, NC, USA. ^[9] Pentara Corporation, Salt Lake City, UT, USA. ^[10]